{"id":6764,"date":"2026-05-07T12:20:30","date_gmt":"2026-05-07T10:20:30","guid":{"rendered":"https:\/\/mediconomics.com\/glossar\/gap-analysis\/"},"modified":"2026-05-07T12:20:30","modified_gmt":"2026-05-07T10:20:30","slug":"gap-analysis","status":"publish","type":"glossary","link":"https:\/\/mediconomics.com\/en\/glossar\/gap-analysis\/","title":{"rendered":"Gap Analysis"},"content":{"rendered":"

Gap Analysis<\/strong> is a structured comparison between a target state (requirements, standards, target process) and the current state (actual practice, existing documents, implemented controls). In the regulated environment of clinical research and quality management, a gap analysis serves to identify deviations, prioritize them, and translate them into actionable measures. It is frequently used before implementing new regulatory requirements or when an organization seeks to systematically improve its compliance maturity. <\/p>\n

Typical Areas of Application in Clinical Research and Regulatory Affairs<\/h2>\n

In clinical trials, sponsors and CROs use gap analyses, for example, when introducing new SOPs, establishing a Quality Management System, or preparing for audits and inspections. A gap analysis is also helpful when transitioning systems (such as electronic data capture or eTMF) to verify whether processes, roles, and technical controls meet requirements. In practice, this involves examining not only “paper compliance” but also whether personnel actually apply the processes and whether evidence is available in an auditable manner. <\/p>\n

For medical devices and in vitro diagnostics, gap analyses are particularly relevant when organizations need to adapt their documentation and clinical evidence to new or amended requirements. The analysis often forms the starting point of an implementation program that may encompass clinical evaluation, post-market processes, or vigilance structures. Particularly during MDR transitions, gap analyses are used to identify missing clinical evidence, unclear roles, or gaps in PMS plans at an early stage. <\/p>\n

Methodology: From Requirements to Measures<\/h2>\n

A robust gap analysis begins with a clear definition of the target state: Which regulatory requirements, guidelines, standards, or internal specifications are relevant? Verifiable criteria are derived from these. In the next step, the current state is assessed, for example through document reviews, interviews, system checks, and sampling in projects. Subsequently, gaps are described, root causes are discussed, and concrete measures are defined. <\/p>\n

It is important that results do not merely end as a list of deficiencies but lead to an actionable plan: responsibilities, priorities, timeline, resources, and evidence of success. Gaps are frequently prioritized according to risk, for example based on whether patient safety, data integrity, or regulatory acceptance is affected. In regulated organizations, the outcome is often transferred into CAPA structures to ensure tracking and effectiveness verification. <\/p>\n

Distinction from Audit, Inspection, and Assessment<\/h2>\n

A gap analysis is typically an internal or commissioned preliminary evaluation aimed at improvement and does not necessarily have the formal character of an audit. An audit often follows a defined audit plan and results in audit findings that are formally tracked. An inspection is a regulatory authority review. An assessment may be broader in scope and may, for example, incorporate maturity models. In practice, the methods may overlap, but the objectives and level of formality differ. <\/p>\n

Particularly in advance of regulatory interactions, a gap analysis is helpful for reducing risks and consolidating one’s own documentation. However, it should be methodologically sound to avoid becoming a risk itself, for example if critical points are identified but not demonstrably addressed. A pragmatic approach is to design the analysis so that it can also be used as a training and change management tool. <\/p>\n

Common Gaps in Practice (and How to Avoid Them)<\/h2>\n

Typical gaps involve unclear responsibilities, inconsistent SOP landscapes, missing training records, incomplete validation documentation, or non-traceable data changes. Interfaces between departments (e.g., Clinical Operations, Data Management, Pharmacovigilance, Regulatory) are also often error-prone because handovers are not clearly defined. Another pattern: processes exist, but implementation is not measurable because KPIs, control points, or regular reviews are missing. <\/p>\n

To avoid such gaps, a pragmatic approach is worthwhile: few, clear criteria; sufficient evidence collection; involvement of process owners; and a CAPA-oriented action plan. It is particularly important to manage changes after the analysis properly, so that new processes are not only written but also implemented, trained, and verified. In practice, this often means: documenting training, embedding checklists in projects, and scheduling regular management reviews. <\/p>\n

Regulatory Reference Points (DE\/EU Focus)<\/h2>\n

Gap analyses frequently refer to GxP requirements and to guidelines that specify Good Clinical Practice and quality management. For clinical trials in the EU, Regulation (EU) No 536\/2014 is a central framework that defines requirements for planning, conduct, documentation, and transparency. For medical devices, MDR 2017\/745 is relevant, particularly regarding clinical evaluation, post-market surveillance, and vigilance. Organizations use gap analyses to verify whether processes and evidence comply with these requirements and where prioritized adjustments are necessary. <\/p>\n

In practice, it is advisable to document the gap analysis in such a way that it also serves as a basis for management decisions: What risks exist, what measures are required, and what timelines are realistic? This transforms the gap analysis into a management tool, not merely a checklist project. <\/p>\n

FAQ<\/strong><\/p>\n

How detailed must a gap analysis be?<\/strong><\/p>\n

As detailed as necessary to clearly derive risks and measures. Analyses that are too broad remain ineffective; analyses that are too detailed tie up disproportionate resources. A risk-based approach is usually appropriate in regulated environments. <\/p>\n

Can a gap analysis replace an audit?<\/strong><\/p>\n

No. An audit typically has formal requirements regarding independence, reporting structure, and follow-up. However, a gap analysis can serve as preparation and helps to reduce audit risks at an early stage. <\/p>\n

What constitutes a good outcome of a gap analysis?<\/strong><\/p>\n

A prioritized action plan with responsibilities, timeline, and evidence that the gaps have been closed. Ideally, it is clear how the effectiveness of the measures will be verified. <\/p>\n

Regulatory References (Selection)<\/strong><\/p>\n

    \n
  • Regulation (EU) No 536\/2014 (Clinical Trials Regulation, CTR)<\/li>\n
  • Regulation (EU) 2017\/745 on Medical Devices (MDR)<\/li>\n
  • ICH E6(R3): Guideline for Good Clinical Practice<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"

    Gap Analysis is a structured comparison between a target state (requirements, standards, target process) and the current state (actual practice, existing documents, implemented controls). In the regulated environment of clinical research and quality management, a gap analysis serves to identify deviations, prioritize them, and translate them into actionable measures. It is frequently used before implementing […]<\/p>\n","protected":false},"author":10,"featured_media":0,"parent":0,"template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"glossary-cat":[],"class_list":["post-6764","glossary","type-glossary","status-publish","hentry"],"acf":[],"related_terms":"","external_url":"","internal_reference_id":"","_links":{"self":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary\/6764","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary"}],"about":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/types\/glossary"}],"author":[{"embeddable":true,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/users\/10"}],"version-history":[{"count":0,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary\/6764\/revisions"}],"wp:attachment":[{"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/media?parent=6764"}],"wp:term":[{"taxonomy":"glossary-cat","embeddable":true,"href":"https:\/\/mediconomics.com\/en\/wp-json\/wp\/v2\/glossary-cat?post=6764"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}